These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 29895749)

  • 1. Functional Regulation of PPARs through Post-Translational Modifications.
    Brunmeir R; Xu F
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
    Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
    Li AC; Binder CJ; Gutierrez A; Brown KK; Plotkin CR; Pattison JW; Valledor AF; Davis RA; Willson TM; Witztum JL; Palinski W; Glass CK
    J Clin Invest; 2004 Dec; 114(11):1564-76. PubMed ID: 15578089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three peroxisome proliferator-activated receptor isotypes from each of two species of marine fish.
    Leaver MJ; Boukouvala E; Antonopoulou E; Diez A; Favre-Krey L; Ezaz MT; Bautista JM; Tocher DR; Krey G
    Endocrinology; 2005 Jul; 146(7):3150-62. PubMed ID: 15790725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone.
    Gaspar JC; Okine BN; Llorente-Berzal A; Roche M; Finn DP
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32102354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation.
    Iannotti FA; Vitale RM
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
    Filip-Ciubotaru F; Manciuc C; Grigore C; Foia L
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
    J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
    Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
    Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc finger protein 407 overexpression upregulates PPAR target gene expression and improves glucose homeostasis in mice.
    Charrier A; Wang L; Stephenson EJ; Ghanta SV; Ko CW; Croniger CM; Bridges D; Buchner DA
    Am J Physiol Endocrinol Metab; 2016 Nov; 311(5):E869-E880. PubMed ID: 27624101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.
    Wadosky KM; Willis MS
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H515-26. PubMed ID: 22037188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Δ
    Hirao-Suzuki M; Takeda S; Watanabe K; Takiguchi M; Aramaki H
    Arch Biochem Biophys; 2019 Feb; 662():219-225. PubMed ID: 30553767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.
    Monsalve FA; Pyarasani RD; Delgado-Lopez F; Moore-Carrasco R
    Mediators Inflamm; 2013; 2013():549627. PubMed ID: 23781121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome-proliferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus.
    Sheldrick EL; Derecka K; Marshall E; Chin EC; Hodges L; Wathes DC; Abayasekara DR; Flint AP
    Biochem J; 2007 Aug; 406(1):175-83. PubMed ID: 17516915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of PPAR activity via phosphorylation.
    Burns KA; Vanden Heuvel JP
    Biochim Biophys Acta; 2007 Aug; 1771(8):952-60. PubMed ID: 17560826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD; Wagner N
    Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella).
    He S; Liang XF; Qu CM; Huang W; Shen D; Zhang WB; Mai KS
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Mar; 155(2):381-8. PubMed ID: 22079418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
    Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
    Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
    Bedu E; Wahli W; Desvergne B
    Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.